Biomonitoring of genotoxic effects for human exposure to nanomaterials: The challenge ahead

Mutation Research - Reviews in Mutation Research

Volumn 768, Issue , 2016, Pages 14-26

  Gonzalez, Laetitia ^a   Kirsch Volders, Micheline ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Human biomonitoring; Lymphocytes; Micronuclei; Nanomaterials

Indexed keywords

NANOMATERIAL; BIOLOGICAL MARKER; MUTAGENIC AGENT;

BIOLOGICAL MONITORING; CANCER RISK; CHEEK CELL; COHORT ANALYSIS; CYTOTOXICITY; DISEASE SURVEILLANCE; ENVIRONMENTAL EXPOSURE; EX VIVO STUDY; GENOTOXICITY; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TARGET CELL; ADVERSE EFFECTS; ANIMAL; ENVIRONMENTAL MONITORING; MUTAGEN TESTING; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; BIOMARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; MUTAGENICITY TESTS; MUTAGENS; NANOSTRUCTURES; OCCUPATIONAL EXPOSURE; TISSUE DISTRIBUTION;

EID: 84960856329     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2016.03.002     Document Type: Review

References (88)

1. Guadagnini R., Halamoda Kenzaoui B., Walker L., Pojana G., Magdolenova Z., Bilanicova D., Saunders M., Juillerat-Jeanneret L., Marcomini A., Huk A., Dusinska M., Fjellsbo L.M., Marano F., Boland S. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 2015, 9(Suppl. 1):13-24.
2. Kain J., Karlsson H.L., Moller L. DNA damage induced by micro- and nanoparticles-interaction with FPG influences the detection of DNA oxidation in the comet assay. Mutagenesis 2012, 27(4):491-500.
3. Gallo V., Egger M., McCormack V., Farmer P.B., Ioannidis J.P., Kirsch-Volders M., Matullo G., Phillips D.H., Schoket B., Stromberg U., Vermeulen R., Wild C., Porta M., Vineis P., Statement S. STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med. 2011, 8(10):e1001117.
4. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8(7):543-557.
5. Sayes C.M., Warheit D.B. Characterization of nanomaterials for toxicity assessment. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1(6):660-670.
6. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61(6):428-437.
7. Foroozandeh P., Aziz A.A. Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res. Lett. 2015, 10:221.
8. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(38):14265-14270.
9. Ali N., Mattsson K., Rissler J., Karlsson H.M., Svensson C.R., Gudmundsson A., Lindh C.H., Jonsson B.A., Cedervall T., Karedal M. Analysis of nanoparticle-protein coronas formed in vitro between nanosized welding particles and nasal lavage proteins. Nanotoxicology 2015, 1-9.
10. Westmeier D., Stauber R.H., Docter D. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM). Toxicol. Appl. Pharmacol. 2015.
11. Petri-Fink A., Steitz B., Finka A., Salaklang J., Hofmann H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm. 2008, 68(1):129-137.
12. Clift M.J., Bhattacharjee S., Brown D.M., Stone V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol. Lett. 2016, 198(3):358-365.
13. Drescher D., Orts-Gil G., Laube G., Natte K., Veh R.W., Osterle W., Kneipp J. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Anal. Bioanal. Chem. 2011, 400(5):1367-1373.
14. Tedja R., Lim M., Amal R., Marquis C. Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano 2012, 6(5):4083-4093.
15. Shi J., Hedberg Y., Lundin M., Odnevall Wallinder I., Karlsson H.L., Moller L. Hemolytic properties of synthetic nano- and porous silica particles: the effect of surface properties and the protection by the plasma corona. Acta Biomater. 2012, 8(9):3478-3490.
16. Corradi S., Gonzalez L., Thomassen L.C., Bilanicova D., Birkedal R.K., Pojana G., Marcomini A., Jensen K.A., Leyns L., Kirsch-Volders M. Influence of serum on in situ proliferation and genotoxicity in A549 human lung cells exposed to nanomaterials. Mutat. Res. 2012, 745(1-2):21-27.
17. Gonzalez L., Corradi S., Thomassen L.C., Martens J.A., Cundari E., Lison D., Kirsch-Volders M. Methodological approaches influencing cellular uptake and cyto-(geno) toxic effects of nanoparticles. J. Biomed. Nanotechnol. 2011, 7(1):3-5.
18. Gonzalez L., Lukamowicz-Rajska M., Thomassen L.C., Kirschhock C.E., Leyns L., Lison D., Martens J.A., Elhajouji A., Kirsch-Volders M. Co-assessment of cell cycle and micronucleus frequencies demonstrates the influence of serum on the in vitro genotoxic response to amorphous monodisperse silica nanoparticles of varying sizes. Nanotoxicology 2014, 8(8):876-884.
19. Hsiao I.L., Huang Y.J. Effects of serum on cytotoxicity of nano- and micro-sized ZnO particles. J. Nanopart. Res. 2013, 15:1829.
20. Dutta D., Sundaram S.K., Teeguarden J.G., Riley B.J., Fifield L.S., Jacobs J.M., Addleman S.R., Kaysen G.A., Moudgil B.M., Weber T.J. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007, 100(1):303-315.
21. Kasper J.Y., Feiden L., Hermanns M.I., Bantz C., Maskos M., Unger R.E., Kirkpatrick C.J. Pulmonary surfactant augments cytotoxicity of silica nanoparticles: studies on an in vitro air-blood barrier model. Beilstein J. Nanotechnol. 2015, 6:517-528.
22. Winkler D.A. Recent advances, and unresolved issues, in the application of computational modelling to the prediction of the biological effects of nanomaterials. Toxicol. Appl. Pharmacol. 2015.
23. Walkey C.D., Olsen J.B., Song F., Liu R., Guo H., Olsen D.W., Cohen Y., Emili A., Chan W.C. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 2014, 8(3):2439-2455.
24. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., Schmid G., Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4(12):2108-2111.
25. Kreyling W.G., Hirn S., Moller W., Schleh C., Wenk A., Celik G., Lipka J., Schaffler M., Haberl N., Johnston B.D., Sperling R., Schmid G., Simon U., Parak W.J., Semmler-Behnke M. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano 2014, 8(1):222-233.
26. Ingle T., Dervishi E., Biris A.R., Mustafa T., Buchanan R.A., Biris A.S. Raman spectroscopy analysis and mapping the biodistribution of inhaled carbon nanotubes in the lungs and blood of mice. J. Appl. Toxicol. 2013, 33(10):1044-1052.
27. Czarny B., Georgin D., Berthon F., Plastow G., Pinault M., Patriarche G., Thuleau A., L'Hermite M.M., Taran F., Dive V. Carbon nanotube translocation to distant organs after pulmonary exposure: insights from in situ (14)C-radiolabeling and tissue radioimaging. ACS Nano 2014, 8(6):5715-5724.
28. Husain M., Wu D., Saber A.T., Decan N., Jacobsen N.R., Williams A., Yauk C.L., Wallin H., Vogel U., Halappanavar S. Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice. Nanotoxicology 2015, 1-10.
29. Geraets L., Oomen A.G., Krystek P., Jacobsen N.R., Wallin H., Laurentie M., Verharen H.W., Brandon E.F., de Jong W.H. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014, 11:30.
30. Pele L.C., Thoree V., Bruggraber S.F., Koller D., Thompson R.P., Lomer M.C., Powell J.J. Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers. Part Fibre Toxicol. 2015, 12:26.
31. Schleh C., Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schaffler M., Schmid G., Simon U., Kreyling W.G. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6(1):36-46.
32. Wang Y., Chen Z., Ba T., Pu J., Chen T., Song Y., Gu Y., Qian Q., Xu Y., Xiang K., Wang H., Jia G. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small 2013, 9(9-10):1742-1752.
33. Filon F.L., Mauro M., Adami G., Bovenzi M., Crosera M. Nanoparticles skin absorption: new aspects for a safety profile evaluation. Regul. Toxicol. Pharm. 2015, 72:310-322.
34. 2 nanoparticles in rats after intravenous injection. PLoS One 2015, 10(4):e0124490.
35. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(9):3357-3362.
36. 2 nanoparticles in vivo using accelerator mass spectrometry. Nano Lett. 2012, 12(11):5532-5538.
37. Huang X., Li L., Liu T., Hao N., Liu H., Chen D., Tang F. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011, 5(7):5390-5399.
38. He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7(2):271-280.
39. Yu T., Hubbard D., Ray A., Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J. Control. Release 2012, 163(1):46-54.
40. Yamashita K., Yoshioka Y., Higashisaka K., Mimura K., Morishita Y., Nozaki M., Yoshida T., Ogura T., Nabeshi H., Nagano K., Abe Y., Kamada H., Monobe Y., Imazawa T., Aoshima H., Shishido K., Kawai Y., Mayumi T., Tsunoda S., Itoh N., Yoshikawa T., Yanagihara I., Saito S., Tsutsumi Y. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 2011, 6(5):321-328.
41. Balansky R., Longobardi M., Ganchev G., Iltcheva M., Nedyalkov N., Atanasov P., Toshkova R., De Flora S., Izzotti A. Transplacental clastogenic and epigenetic effects of gold nanoparticles in mice. Mutat. Res. 2013, 751-752:42-48.
42. Melnik E.A., Buzulukov Y.P., Demin V.F., Demin V.A., Gmoshinski I.V., Tyshko N.V., Tutelyan V.A. Transfer of silver nanoparticles through the placenta and breast milk during in vivo experiments on rats. Acta Naturae. 2013, 5(3):107-115.
43. Wick P., Malek A., Manser P., Meili D., Maeder-Althaus X., Diener L., Diener P.A., Zisch A., Krug H.F., von Mandach U. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 2010, 118(3):432-436.
44. Liou S.H., Tsai C.S., Pelclova D., Schubauer-Berigan M.K., Schulte P.A. Assessing the first wave of epidemiological studies of nanomaterial workers. J. Nanopart. Res. 2015, 17:413.
45. Mackevica A., Foss Hansen S. Release of nanomaterials from solid nanocomposites and consumer exposure assessment-a forward-looking review. Nanotoxicology 2016, 1-13.
46. Zupke O., Distler E., Jurchott A., Paiphansiri U., Dass M., Thomas S., Hartwig U.F., Theobald M., Landfester K., Mailander V., Herr W. Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release. Nanomedicine (Lond) 2015, 10(7):1063-1076.
47. Magdolenova Z., Drlickova M., Henjum K., Runden-Pran E., Tulinska J., Bilanicova D., Pojana G., Kazimirova A., Barancokova M., Kuricova M., Liskova A., Staruchova M., Ciampor F., Vavra I., Lorenzo Y., Collins A., Rinna A., Fjellsbo L., Volkovova K., Marcomini A., Amiry-Moghaddam M., Dusinska M. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 2015, 9(Suppl. 1):44-56.
48. Tavares A.M., Louro H., Antunes S., Quarre S., Simar S., De Temmerman P.J., Verleysen E., Mast J., Jensen K.A., Norppa H., Nesslany F., Silva M.J. Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. Toxicol. In Vitro 2014, 28(1):60-69.
49. Magdolenova Z., Collins A., Kumar A., Dhawan A., Stone V., Dusinska M. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology 2014, 8(3):233-278.
50. Costa P.M., Fadeel B. Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk. Toxicol. Appl. Pharmacol. 2015.
51. Riebeling C., Wiemann M., Schnekenburger J., Kuhlbusch T.A., Wohlleben W., Luch A., Haase A. A redox proteomics approach to investigate the mode of action of nanomaterials. Toxicol. Appl. Pharmacol. 2016.
52. Stoccoro A., Karlsson H.L., Coppede F., Migliore L. Epigenetic effects of nano-sized materials. Toxicology 2013, 313(1):3-14.
53. Smolkova B., El Yamani N., Collins A.R., Gutleb A.C., Dusinska M. Nanoparticles in food. Epigenetic changes induced by nanomaterials and possible impact on health. Food Chem. Toxicol. 2015, 77:64-73.
54. Iavicoli I., Leso V., Schulte P.A. Biomarkers of susceptibility: state of the art and implications for occupational exposure to engineered nanomaterials. Toxicol. Appl. Pharmacol. 2015.
55. Lu X., Miousse I.R., Pirela S.V., Melnyk S., Koturbash I., Demokritou P. Short-term exposure to engineered nanomaterials affects cellular epigenome. Nanotoxicology 2015, 1-11.
56. Lu X., Miousse I.R., Pirela S.V., Moore J.K., Melnyk S., Koturbash I., Demokritou P. In vivo epigenetic effects induced by engineered nanomaterials: A case study of copper oxide and laser printer-emitted engineered nanoparticles. Nanotoxicology 2015, 1-11.
57. Zhao X., Striolo A., Cummings P.T. C60 binds to and deforms nucleotides. Biophys. J. 2005, 89(6):3856-3862.
58. Jin P., Chen Y., Zhang S.B., Chen Z. Interactions between Al(1)(2)X (X = Al, C, N and P) nanoparticles and DNA nucleobases/base pairs: implications for nanotoxicity. J. Mol. Model. 2012, 18(2):559-568.
59. Li K., Zhao X., Hammer B.K., Dut S., Chen Y. Nanoparticles inhibit DNA replication by binding to DNA: modeling and experimental validation. ACS Nano 2013, 7(11):9664-9674.
60. An H., Liu Q., Ji Q., Jin B. DNA binding and aggregation by carbon nanoparticles. Biochem. Biophys. Res. Commun. 2010, 393(4):571-576.
61. Kermanizadeh A., Chauche C., Brown D.M., Loft S., Moller P. The role of intracellular redox imbalance in nanomaterial induced cellular damage and genotoxicity: a review. Environ. Mol. Mutagen. 2015, 56(2):111-124.
62. Di Bucchianico S., Fabbrizi M.R., Cirillo S., Uboldi C., Gilliland D., Valsami-Jones E., Migliore L. Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticles. Int. J. Nanomed. 2014, 9:2191-2204.
63. Gonzalez L., Lison D., Kirsch-Volders M. Genotoxicity of engineered nanomaterials: A critical review. Nanotoxicology 2008, 2(4):252-273.
64. Apopa P.L., Qian Y., Shao R., Guo N.L., Schwegler-Berry D., Pacurari M., Porter D., Shi X., Vallyathan V., Castranova V., Flynn D.C. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol. 2009, 6:1.
65. Xu F., Piett C., Farkas S., Qazzaz M., Syed N.I. Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol. Brain 2013, 6:29.
66. Tay C.Y., Cai P., Setyawati M.I., Fang W., Tan L.P., Hong C.H., Chen X., Leong D.T. Nanoparticles strengthen intracellular tension and retard cellular migration. Nano Lett. 2014, 14(1):83-88.
67. Gonzalez L., Thomassen L.C., Plas V., Napierska D., Decordier I., Roelants M., Hoet P.H., Kirschhock C.E., Martens J.A., Lison D., Kirsch-Volders M. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models. Nanotoxicology 2010, 4:382-395.
68. Gonzalez L., De Santis Puzzonia M., Ricci R., Aureli F., Guarguaglini G., Cubadda F., Leyns L., Cundari E., Kirsch-Volders M. Amorphous silica nanoparticles alter microtubule dynamics and cell migration. Nanotoxicology 2014, 1-8.
69. 2 long-term exposure. Toxicol. Appl. Pharmacol. 2009, 241(2):182-194.
70. Bourdon J.A., Saber A.T., Jacobsen N.R., Jensen K.A., Madsen A.M., Lamson J.S., Wallin H., Moller P., Loft S., Yauk C.L., Vogel U.B. Carbon black nanoparticle instillation induces sustained inflammation and genotoxicity in mouse lung and liver. Part Fibre Toxicol. 2012, 9:5.
71. Muller J., Decordier I., Hoet P.H., Lombaert N., Thomassen L., Huaux F., Lison D., Kirsch-Volders M. Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis 2008, 29(2):427-433.
72. Sadeghiani N., Barbosa L.S., Silva L.P., Azevedo R.B., Morais P.C., Lacava Z.G.M. Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J. Magn. Magn. Mater. 2005, 289:466-468.
73. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69(22):8784-8789.
74. Tarantini A., Huet S., Jarry G., Lanceleur R., Poul M., Tavares A., Vital N., Louro H., Joao Silva M., Fessard V. Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 1: oral route. Environ. Mol. Mutagen. 2015, 56(2):218-227.
75. Sycheva L.P., Zhurkov V.S., Iurchenko V.V., Daugel-Dauge N.O., Kovalenko M.A., Krivtsova E.K., Durnev A.D. Investigation of genotoxic and cytotoxic effects of micro- and nanosized titanium dioxide in six organs of mice in vivo. Mutat. Res. 2011, 726(1):8-14.
76. Chen Z., Wang Y., Ba T., Li Y., Pu J., Chen T., Song Y., Gu Y., Qian Q., Yang J., Jia G. Genotoxic evaluation of titanium dioxide nanoparticles in vivo and in vitro. Toxicol. Lett. 2014, 226(3):314-319.
77. Khalil W.K., Girgis E., Emam A.N., Mohamed M.B., Rao K.V. Genotoxicity evaluation of nanomaterials: dna damage, micronuclei, and 8-hydroxy-2-deoxyguanosine induced by magnetic doped CdSe quantum dots in male mice. Chem. Res. Toxicol. 2011, 24(5):640-650.
78. Catalan J., Siivola K.M., Nymark P., Lindberg H., Suhonen S., Jarventaus H., Koivisto A.J., Moreno C., Vanhala E., Wolff H., Kling K.I., Jensen K.A., Savolainen K., Norppa H. In vitro and in vivo genotoxic effects of straight versus tangled multi-walled carbon nanotubes. Nanotoxicology 2016, 1-13.
79. Tarantini A., Lanceleur R., Mourot A., Lavault M.T., Casterou G., Jarry G., Hogeveen K., Fessard V. Toxicity, genotoxicity and proinflammatory effects of amorphous nanosilica in the human intestinal Caco-2 cell line. Toxicol. In Vitro 2015, 29(2):398-407.
80. Kuhlbusch T.A., Asbach C., Fissan H., Gohler D., Stintz M. Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol. 2011, 8:22.
81. Ferraro D., Anselmi-Tamburini U., Tredici I.G., Ricci V., Sommi P. Overestimation of nanoparticles-induced DNA damage determined by the comet assay. Nanotoxicology 2016, 1-10.
82. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28(3):625-631.
83. Decordier I., Papine A., Vande Loock K., Plas G., Soussaline F., Kirsch-Volders M. Automated image analysis of micronuclei by IMSTAR for biomonitoring. Mutagenesis 2011, 26(1):163-168.
84. Kirsch-Volders M., Plas G., Elhajouji A., Lukamowicz M., Gonzalez L., Vande Loock K., Decordier I. The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch. Toxicol. 2011, 85(8):873-899.
85. O'Callaghan-Gordo C., Fthenou E., Pedersen M., Espinosa A., Chatzi L., Beelen R., Chalkiadaki G., Decordier I., Hoek G., Merlo D.F., Nieuwenhuijsen M., Roumeliotaki T., Vafeiadi M., Loock K.V., Kleinjans J., Stephanou E., Kirsch-Volders M., Kogevinas M. Outdoor air pollution exposures and micronuclei frequencies in lymphocytes from pregnant women and newborns in Crete, Greece (Rhea cohort). Environ. Res. 2015, 143(Pt A):170-176.
86. Bolognesi C., Fenech M. Micronucleus assay in human cells: lymphocytes and buccal cells. Methods Mol. Biol. 2013, 1044:191-207.
87. Bolognesi C., Roggieri P., Ropolo M., Thomas P., Hor M., Fenech M., Nersesyan A., Knasmueller S. Buccal micronucleus cytome assay: results of an intra- and inter-laboratory scoring comparison. Mutagenesis 2015, 30(4):545-555.
88. Xie G., Sun J., Zhong G., Shi L., Zhang D. Biodistribution and txicity of intravenously administered silica nanoparticles in mice. Arch. Toxicol. 2010, 84:183-190.